Maravai Lifesciences Holdings MRVI Cash Flow Statement (2020-2026)

NASDAQ MRVI
$8.02 +0.50 (+6.65%)
At close: Nov 9, 2026 · 4:00 PM EST
Reported Financials

Maravai Lifesciences Holdings Quarterly Cash Flow Statement

Periods 27 quarters
Latest Sep 2026

Maravai Lifesciences Holdings reported cash from operations of $5.01M and free cash flow of $4.49M for the quarter ended Sep 2026, up 133.1% year over year. This cash flow statement covers 27 quarters of results from Mar 2020 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
127.11M146.86M156.72M99.65M87.43M-1.35M-11.94M-15.10M-109.98M-22.68M-18.42M-172.46M-46.07M-52.85M-69.84M-45.06M-63.02M-6.38M-21.63M-24.00M
Depreciation and DepletionDep. & Depletion
1.75M1.86M1.89M1.86M2.00M2.08M2.82M4.07M3.93M4.79M5.56M5.04M5.51M5.69M5.96M5.98M5.98M4.90M5.31M5.74M
Depreciation, Depletion & Amortization
Amortization of IntangiblesAmort. of Intangibles
3.65M5.53M6.25M6.25M6.24M6.77M6.85M6.87M6.87M6.87M6.87M6.89M6.90M7.03M7.20M7.21M6.51M6.47M6.47M6.47M
Amortization of Deferred ChargesAmort. Deferred Charges
0.68M0.70M0.71M0.72M0.65M0.72M0.73M0.74M0.74M0.74M0.74M0.75M0.66M0.46M0.39M0.40M0.40M
Depreciation & Amortization (CF)Dep. & Amort.
1.75M1.86M1.89M1.86M2.00M2.08M2.82M4.07M3.93M4.79M5.56M5.04M5.51M5.69M5.96M5.98M5.98M4.90M5.31M5.74M
Share-based CompensationStock Comp.
2.23M3.63M4.31M4.74M6.00M5.99M9.27M9.99M9.34M12.06M13.76M13.05M10.55M10.40M6.79M9.06M3.93M6.74M10.21M10.12M
Deferred Taxes
17.47M13.22M12.86M9.23M7.01M-1.52M-2.76M-5.53M764.75M0.01M
Gains from Sales and DivestituresGains Divest
Gains from Investment SecuritiesGains Investment
-0.88M1.92M
Asset Writedowns and ImpairmentWritedown
154.24M11.91M12.44M30.45M41.71M0.61M-0.14M2.05M
Other non-cash itemsOther Non-Cash
6.25M-9.04M-7.80M5.46M3.17M-2.42M3.39M-668.25M2.32M-1.20M-0.18M5.05M2.41M2.65M1.21M2.15M3.01M
Change in Working Capital
Change in ReceivablesChange Receivables
51.54M2.22M0.12M-5.83M25.77M-82.41M-7.56M-3.21M8.79M-17.88M-1.89M-6.02M11.43M-10.16M-0.50M-5.12M2.96M7.91M-2.29M-5.44M
Change in InventoryChange Inventory
-5.48M-1.20M8.70M2.31M-19.27M3.38M-7.71M1.50M2.18M-0.82M-0.70M1.60M-0.45M-0.45M-3.11M-1.35M-3.09M-0.03M0.77M2.02M
Change in Account PayablesChange Payables
-0.87M1.95M4.36M-4.42M-3.47M-0.24M1.87M1.99M1.66M-3.68M4.57M-2.42M2.25M-0.71M1.78M-2.91M-5.52M6.16M-1.80M-0.30M
Change in Accrued ExpensesChange Accrued Exp.
7.47M-4.06M2.29M15.89M-5.61M24.23M-17.64M2.38M6.40M-24.12M3.00M-1.06M-1.56M1.84M4.80M2.25M-13.51M-5.34M1.82M-5.25M
Change in Other Operating AssetsOther Assets Change
3.48M-2.52M12.57M26.32M-0.48M23.01M-21.29M-3.48M-6.38M-0.73M0.20M-0.44M-1.00M-2.24M2.86M-1.07M-1.36M-1.43M0.77M-1.18M
Change in Other Operating LiabilitiesOther Liabilities Change
-57.46M-7.63M3.61M1.38M-0.66M-11.66M-2.25M-0.99M-1.08M-2.28M-3.79M0.92M-1.15M-8.49M-6.19M-2.06M-1.89M-0.20M-1.69M3.90M
Other Working Capital ChangesOther WC Changes
-60.94M-5.11M-8.96M-24.94M-0.18M-34.67M19.05M2.49M5.29M-1.55M-3.99M1.36M-0.15M-6.25M-9.05M-0.99M-0.53M1.23M-2.46M5.08M
Cash from OperationsCash from Ops.
58.74M162.30M164.28M110.06M99.34M85.07M19.19M14.17M7.79M-8.47M17.43M13.14M-14.64M-9.39M-10.27M-15.15M-22.77M8.67M3.99M5.02M
Investing Activities
Capital ExpendituresCapex
5.66M2.75M1.66M6.47M6.21M7.87M25.06M15.83M16.80M5.67M9.55M8.59M5.85M4.50M2.87M3.66M2.11M4.44M0.37M0.52M
Sales of Property, Plant and EquipmentPP&E (Sale)
Change in Property, Plant and EquipmentChange in PP&E
-5.66M-2.75M-1.66M-6.47M-6.21M-7.87M-25.06M-15.83M-16.80M-5.67M-9.55M-8.59M-5.85M-4.50M-2.87M-3.66M-2.11M-4.44M-0.37M-0.52M
Change in IntangiblesChange Intangibless
0.50M
Acquisitions
238.84M0.13M69.73M-0.11M18.63M0.36M
Net of Acquisitions & DivestmentsNet Acquisitions
-238.84M-0.13M-69.73M0.11M-18.63M-0.36M
Cash from Investing ActivitiesCash from Investing
-5.66M-241.58M-1.66M-5.85M-18.52M-69.73M-24.16M-15.52M-12.90M-4.24M-6.18M-8.96M-4.93M-23.13M-3.24M-2.93M-2.11M-4.44M-0.37M-0.52M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
8.46M
Long-Term Debt RepaymentsLT Debt Repayment
1.50M9.82M1.36M1.36M0.07M0.12M1.17M1.51M1.51M1.52M229.86M1.36M1.36M1.93M0.79M51.36M242.88M
Net Long-Term Debt Issued (Repaid)Net LT Debt
-1.50M-1.36M-1.36M-1.36M-0.07M-0.12M-1.17M-1.51M-1.51M-1.52M-229.86M-1.36M-1.36M-1.93M-0.79M-51.36M-242.88M
Net Debt Issuances and RepaymentsNet Debt Issuance
-1.50M-1.36M-1.36M-1.36M-0.07M-0.12M-1.17M-1.51M-1.51M-1.52M-229.86M-1.36M-1.36M-1.93M-0.79M-51.36M-242.88M
Change in Capital Stock
Common Stock IssuedStock Issued
0.38M0.73M0.54M0.73M0.37M0.31M
Net Shares Issued and RepurchasedNet Shares Issued
0.38M0.73M0.54M0.73M0.37M0.31M
Net Equity Issued and RepurchasedNet Equity Issued
0.38M0.73M0.54M0.73M0.37M0.31M
Other financing activities (as filed)
-47.15M-39.89M-42.59M-36.81M-30.92M-7.81M0.09M1.96M-40.28M2.38M1.76M2.35M-7.32M-3.54M4.55M-6.43M-5.64M-3.87M-0.16M-0.24M
Cash from Financing ActivitiesCash from Financing
-49.58M-40.52M-43.41M-37.44M-66.12M-19.21M-43.13M0.78M0.47M-0.56M0.23M0.81M-236.19M-4.90M-1.53M-8.25M-1.82M-55.23M-98.98M-1.57M
Additional items
Exchange Rate EffectFX Effect
-0.13M0.07M-0.11M-0.01M0.01M0.03M0.02M0.01M
Change in Cash
3.37M-119.80M119.21M66.77M14.69M-3.87M-48.10M-0.57M-4.64M-13.27M11.48M4.99M-255.76M-37.35M-15.15M-26.33M-26.68M-50.97M-95.34M2.93M
Ending Cash Balance
551.27M431.47M550.68M617.45M632.14M628.27M580.18M579.61M574.96M561.69M573.17M578.16M322.40M285.05M269.91M243.57M216.89M165.92M70.58M73.51M
Free Cash FlowFCF
53.09M159.56M162.62M103.59M93.12M77.21M-5.87M-1.66M-9.01M-14.13M7.88M4.55M-20.49M-13.89M-13.14M-18.81M-24.88M4.23M3.62M4.49M
Net Cash FlowNCF
3.51M-119.80M119.21M66.77M14.69M-3.87M-48.10M-0.57M-4.64M-13.27M11.48M4.99M-255.76M-37.42M-15.04M-26.33M-26.70M-51.00M-95.36M2.92M
Interest Paid
6.62M1.37M4.76M5.28M8.78M9.59M11.02M11.58M12.07M12.14M11.87M11.86M15.11M6.52M6.12M6.13M6.21M6.15M7.59M3.94M
Income Taxes PaidTaxes Paid
5.90M0.91M12.94M5.73M3.45M-0.52M0.45M-3.01M0.09M0.20M0.18M0.27M0.03M0.14M-0.67M-0.03M0.01M0.01M

Maravai Lifesciences Holdings Cash Flow Statement API

Pull Maravai Lifesciences Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=MRVI&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY